Enabling faster and more accurate treatment of Tuberculosis
Submitting Institution
University of BirminghamUnit of Assessment
Clinical MedicineSummary Impact Type
TechnologicalResearch Subject Area(s)
Medical and Health Sciences: Medical Microbiology
Summary of the impact
In 2010, 8,483 cases of tuberculosis (TB) were reported in the UK, mainly
in urban areas and with London and the West Midlands having the highest
rates of disease (rate within Heartlands Primary Care Trust 80+ per
100,000). Research led by Professor Peter Hawkey at the University of
Birmingham has resulted in the development of novel techniques for real
time typing of Mycobacterium tuberculosis strains. The new
cost effective and rapid methodology has been adopted by the three UK
national reference laboratories and has resulted in significant
improvements to the national TB typing scheme and TB infection management.
An associated secure IT system has been developed to enable TB control
teams to rapidly receive typing data together with an analysis of the
local cases. This has influenced changes in clinical practice by reducing
the need for contact tracing. Use of the new techniques developed at
Birmingham has resulted in faster, more accurate identification of
outbreaks of TB and this information has been used to significantly
improve patient management.
Underpinning research
In the management of suspected outbreaks of TB infection it is critical
to identify the specific strain of M. tuberculosis for all
potentially linked isolates, known as typing, so that identical strains in
apparently unlinked cases can be identified and treatment initiated.
Previously TB typing used a slow and complex method involving cultivation
of sputum samples on solid media (3-6 weeks), and a nucleic acid
restriction digest assay (25% failure rate and takes 5 days). This method
was expensive and was therefore only applied to a small number of cultured
isolates.
An alternative and improved strain typing method was developed at the
University of Birmingham by Professor Peter Hawkey, Professor of Public
Health and Clinical Bacteriology with laboratory work undertaken by Dr
Jason Evans, Clinician Scientist at Heart of England NHS Foundation Trust.
The method is based on the amplification of previously identified variable
number tandem repeat (VNTR) DNA sequences in the M. tuberculosis
genome from liquid cultures and quantification of the number of repeat
sequences using denaturing high performance chromatography (dHPLC) (≤ 14
days, first time used for mycobacterial typing) [1]. The team developed
and validated novel polymerase chain reaction primers to amplify these
sequences and applied them to collections of known and unknown M.
tuberculosis strains [2].
As a result of preliminary work from 2001 to 2003 (funded by Health
Protection Agency (HPA), a further £175k was secured from the Department
of Health, which enabled the further development and validation of the use
of the dHPLC VNTR technique for routine clinical typing of M.
tuberculosis. The test was first implemented into clinical service
at the Public Health Laboratories at Heart of England NHS Foundation Trust
in 2001 and by 2004 all TB isolates going through the Heartlands service
were being typed using the new technique. Data from the clinical service
at Heartlands Hospital was used to further understand the worldwide
evolution of M. tuberculosis, as well as carefully dissecting the
phylogeny of strains from the Birmingham South Asian community [3, 4].
In 2007 a cluster of Mycobacterium bovis (normally found in
cattle) infections was identified in patients in Birmingham. In
collaboration with Animal Health and Veterinary Laboratories Agency,
University College London, Health Protection Surveillance Units and the
Welsh Zoonoses Surveillance Unit, the dHPLC VNTR technique was used to
identify for the first time M. bovis human to human transmission
in individuals using recreational steroids [5].
Using the dHPLC VNTR technique Professor Peter Hawkey's team has also
been able to identify the world's largest reported cluster (≥ 400
patients) of cross infection caused by a single M. tuberculosis
strain (Mercian Strain), which has demonstrated that this strain is
associated with UK born Caribbean individuals who use recreational drugs
in a highly restricted geographical location based on epidemiological work
combined with DNA fingerprinting [6].
Professor Hawkey and Dr Evans have also led the development of a software
platform to support the HPA's national TB typing scheme. The OriginsInfo
software was originally developed by Professor Webber of UCL and utilises
given and family names to predict cultural, ethnic and linguistic origins
of patients. The adaptation of the software by Professor Hawkey and Dr
Evans to the TB setting has enabled the identification of otherwise
unsuspected social links e.g. a group of Lithuanian immigrant workers in
illegal accommodation, which when combined with the new typing technique
controlled this and many other outbreaks [7].
References to the research
5. Evans JT, Smith EG, Banerjee A, Smith RM, Dale J, Innes JA,
Hunt D, Tweddell A, Wood A, Anderson C, Hewinson RG, Smith NH, Hawkey PM,
Sonnenberg P. Cluster
of human tuberculosis caused by Mycobacterium bovis: evidence
for person-to-person transmission in the UK. Lancet. 2007
Apr;369(9569):1270-6. http://dx.doi.org/10.1016/S0140-6736(07)60598-4
6. Evans JT, Serafino Wani RL, Anderson L, Gibson AL, Smith EG,
Wood A, Olowokure B, Abubakar I, Mann JS, Gardiner S, Jones H, Sonnenberg
P, Hawkey PM. A
geographically-restricted but prevalent Mycobacterium
tuberculosis strain identified in the West Midlands Region of the UK
between 1995 and 2008. PLoS One. 2011 Mar 25;6(3):e17930 doi:10.1371/journal.pone.0017930
7. Evans et al, Global Origin of Mycobacterium tuberculosis in
the Midlands, UK. Emerging Infectious Diseases. 2010; 16:3, 542 DOI:
10.3201/eid1603.090813
Details of the impact
The research described above resulted in the development of a real time
typing method for M. tuberculosis, which has resulted in a
nationwide change in the methodology used for typing of TB, significant
improvements to the national TB typing scheme and the management of TB
infections.
Delivery of a National Reference Standard
Prior to the outcomes from this research there was no prospect of
real-time high volume accurate typing being provided for English isolates
of M. tuberculosis. The UK National Reference Laboratories used a
complex, slow and unreliable technique, which only provided results on 75%
of strains which would then require re-typing using a second method,
followed by further analysis to identify specific strain types. The
research conducted by Professor Peter Hawkey at the University of
Birmingham resulted in a low cost, high volume dHPLC method, with new
primers and targets that provides real-time typing of M. tuberculosis.
The new typing method was fully implemented into clinical service at the
Birmingham National Reference Laboratories for Mycobacterium
tuberculosis, based at Heart of England NHS Foundation Trust in 2004
and continues to be used until the present day. As a result of the early
work completed by the National Reference Laboratory in Birmingham, where
all isolates were typed and which showed that unsuspected clusters of
cross-infection were occurring, the universal rapid MIRU-VNTR 24 locus
typing was recognised as a key component to enable the delivery of the
Chief Medical Officer's TB action plan [1], which was published in October
2004 and detailed that "molecular strain typing of all M. tuberculosis
isolates and the establishment of a central database linking
epidemiological data is a key component of TB control". Whilst the
publication of document is outside the period of assessment it provided
the necessary mandate for the other National Reference Laboratories
(London and Newcastle) to adopt the rapid typing technology developed by
Professor Peter Hawkey, this occurred fully in 2010.
Professor Hawkey was a member of the TB Diagnosis and Molecular
Epidemiology (DAME) Group in the HPA which was responsible for producing a
national strategy for TB diagnosis. The Chair of DAME, Prof Pete Borriello
(Chief Executive of the Veterinary Medicines Directorate), detailed in a
statement to accompany this case study that "the research undertaken at
Birmingham to see if the emerging molecular strain differentiation
techniques could be applied to this problem and turn molecular typing into
a useful public health tool was very important" [2]. The DAME Group argued
successfully for the adoption of the Midlands' TB typing model nationally.
The service model for M. tuberculosis typing established in
Birmingham was adopted by the HPA to deliver molecular typing of every
isolate via the HPA National Strain typing project, which began in January
2010 and is described in the HPA question and answer sheet published in
February 2011 [3] and the 2012 HPA report on TB in the UK [4]. Dr P Monk,
Consultant in Health Protection from the HPA, detailed the following in a
statement to accompany this case study: "as a result of the work you
[Professor Peter Hawkey] have led, there has been a step change in the
control of TB. The developments of strain typing which came out of the
research you led have allowed us to introduce a national strain typing
service" [5].
The Birmingham strategy of direct real time reporting on the VNTR targets
has become the national reference standard and is currently used in the
other two reference labs (London and Newcastle) for England, Cardiff for
Wales and Edinburgh for Scotland, as detailed in the National Institute
for Health and Clinical Excellence guidance on the clinical diagnosis and
management of tubercuosis [6], which was published in November 2010. A
compatible variant of the technique is also used in USA, Canada, France,
Holland and Germany [7].
Impact on public health
All M. Tuberculosis isolates in the UK are now typed by the
National Reference Laboratories which are a critical component of the
national Public Health England TB typing surveillance tool used by public
health physicians to delineate and recognise clusters of TB
cross-infection. The new typing technology has meant that pseudo outbreaks
can be rapidly identified, i.e. individuals incorrectly thought to have
acquired TB can be rapidly excluded, thus reducing the time and money
spent on contact tracing. The use of the rapid typing method in the TB
typing project has meant that isolates indistinguishable from those in
previous cases reported to Health Protection Units, regional teams and
nationally could be linked and controlled as a direct result of the typing
information. Possible epidemiologically linked cases are investigated to
ascertain whether an epidemiological cluster or outbreak exists. Any
ensuing outbreak investigation aims to identify and treat all cases of
active disease to prevent further transmission.
The public health community are now provided with detailed information on
the relationship of different strains of TB. The strain typing data when
integrated with epidemiological and social information via Origins
software provides a powerful tool for Health Protection Units to recognise
and track clusters of TB. Origins is a database which assigns a cultural,
ethnic and linguistic group based on personal and family name; its
application to TB epidemiology was developed by Prof Hawkey. Data detailed
by the HPA through their TB Strain Typing and Cluster Investigation
Newsletters provides an indication of the level of clusters being
investigated in the UK. In the period Jan 2011-Dec 2012, of the 144
clusters being actively investigated by Public Health teams, 40 were from
London and 41 from the Midlands [8]; this disproportionate use represents
the early adopter status in the Midlands. This level of investigation has
only been made possible by the implementation of the rapid typing
technology and associated epidemiological and social information provided
via Origins. The method has also enabled the almost complete eradication
of laboratory contamination being responsible for false positives; prior
to typing 8% of positive results were contamination.
Impact on patients
The early identification of TB patients, which are part of previously
unidentified clusters of infection, is enabling early treatment and
avoidance of morbidity and mortality, as detailed in a study from the
Netherlands and in the report from the HPA on Surveillance of Mycobacterium
tuberculosis Strain Typing [7, 9].
Impact on local clinical practice
In 2006, the University of Birmingham team established a secure website
(Document Gateway) so that TB teams across East and West Midlands could
access the data in real-time. This was so successful that from 2008
onwards Birmingham and Black Country isolates have been managed in monthly
multidisciplinary meetings with clinicians directly responsible for
managing the patients, public health clinicians and TB control nurses
examining typing data. In January 2010, in response to requests from users
and through the continuing support from the HPA, the service was expanded
in parallel with nationally agreed guidelines and increased the resolution
to beyond that of the methodology originally used by the main reference
lab. This work was done by Dr Evans, Dr Grace Smith (Head of Regional
Reference Laboratory) and Professor Peter Hawkey working directly with
clinicians.
Sources to corroborate the impact
- Chief Medical Officer's TB Action Plan published in 2004
- Letter from the Chief Executive of Defra's Veterinary Medicines
Directorate (VMD)
- Q & A sheet for HPA National Tuberculosis Strain Typing project,
published February 2011
- HPA Report: Tuberculosis in the UK, published in 2012
- Letter from the Health Protection Agency, East Midlands South Health
Protection Unit, County Hall, Glenfield, Leicestershire, LE3 8TB
- NICE Clinical Guideline. Tuberculosis: Clinical diagnosis and
management of tuberculosis, and measures for its prevention and control.
Published March 2011
- de Beer et al, Comparative Study of IS6110 Restriction Fragment Length
Polymorphism and Variable-Number-Tandem-Repeat Typing of Mycobacterium
tuberculosis Isolates in the Netherlands, Based on a 5-Year Nationwide
Survey, Journal of Clinical Microbiology. 2013, 51:1193
- HPA TB Strain Typing & Cluster Newsletter published January 2013
- HPA Surveillance of Mycobacterium tuberculosis Strain Typing